Cohen, Talia R. BA; Mujica, Christin A. BS; Gardner, Margaret E. BS; Hwang, Melissa BS; Karmacharya, Rakesh MD, PhD
From the Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA; Harvard Medical School (Dr. Karmacharya); Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA (Dr. Karmacharya).
Supported by a Robert Wood Johnson Foundation Clinical Scholar award, National Institute of Mental Health Biobehavioral Research Awards for Innovative New Scientists (BRAINS) award no. R01MH113858, Doris Duke Charitable Foundation Clinical Scientist Development Award, and by Steve Willis and Elissa Freud (all to Dr. Karmacharya).
Original manuscript received 4 September 2019; revised manuscript received 14 January 2020, accepted for publication subject to revision 12 March 2020; revised manuscripts received 30 March and 19 May 2020.
Correspondence: Rakesh Karmacharya, MD, PhD, McLean Hospital, 115 Mill St., MS 108, Belmont, MA 02478. Email: [email protected]
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.harvardreviewofpsychiatry.org).
